O'Brien, 2023 - Google Patents

Self-Assembling Peptide-Based High-Relaxivity Prostate-Cancer-Targeted MRI Contrast Agents

O'Brien, 2023

View PDF
Document ID
4060938874756685897
Author
O'Brien A
Publication year

External Links

Snippet

Abstract Magnetic Resonance Imaging (MRI) is a widely used, highly effective imaging method for diagnosing cancer and guiding treatment. MRI contrast agents enhance image quality, with higher relaxivity (r 1) contrast agents providing the best utility. Attaching a …
Continue reading at repository.rit.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
US11020493B2 (en) Double-labeled probe for molecular imaging and use thereof
CA2455638C (en) Peptide-based multimeric targeted contrast agents
Seward et al. Peptide-mediated cellular uptake of cryptophane
US12156920B2 (en) Double-labeled probe for molecular imaging and use thereof
AU2018373675B2 (en) A double-labeled probe for molecular imaging and use thereof
JP2003201258A (en) Targeting multimeric imaging agents through multidentate binding
US9284381B2 (en) Methods and reagents for preparing multifunctional probes
Tripepi et al. Synthesis of high relaxivity gadolinium AAZTA tetramers as building blocks for bioconjugation
Wu et al. Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma
US20150297761A1 (en) Peptidic structures incorporating an amino acid metal complex and applications in magnetic resonance imaging
Pierri et al. Advances in MRI: Peptide and peptidomimetic‐based contrast agents
O'Brien Self-Assembling Peptide-Based High-Relaxivity Prostate-Cancer-Targeted MRI Contrast Agents
Yang et al. Design, synthesis, and in vitro evaluation of a binary targeting MRI contrast agent for imaging tumor cells
Accardo et al. Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications
Caravan et al. A lysine walk to high relaxivity collagen-targeted MRI contrast agents
Zhang et al. Effect of peptide-chelate architecture on the metabolic stability of peptide-based MRI contrast agents
US20240115744A1 (en) Fibrin-binding compounds for imaging and treatment
KR102953752B1 (en) urokinase plasminogen activator receptor-targeting peptide
O'Brien et al. Self‐Assembling Peptide‐Based High‐Relaxivity Targeted MRI Contrast Agents
Kaur Synthesis of Single-Modal and Dual-Modal Targeted Molecular Imaging Agents for MRI-NIR Imaging of Breast Cancer
WO2016066638A1 (en) Metal biosensors based on compounds with metal-sensitive chemical shifts for magnetic resonance spectroscopy and imaging and their uses
US20250073355A1 (en) Cd44-binding peptide reagents and methods